Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications

Research output: Contribution to journalReview ArticleScientificpeer-review

Original languageEnglish
JournalTrends in Pharmacological Sciences
Volume33
Issue number6
Pages (from-to)312-322
Number of pages11
ISSN0165-6147
DOIs
Publication statusPublished - 2012
MoE publication typeA2 Review article in a scientific journal

Fields of Science

  • DIPEPTIDYL PEPTIDASE-4 INHIBITOR
  • TRANSPORTING POLYPEPTIDE 1B1
  • CYP3A4 IN-VITRO
  • HEALTHY-SUBJECTS
  • PLASMA-CONCENTRATIONS
  • GENETIC POLYMORPHISMS
  • REPAGLINIDE PHARMACOKINETICS
  • CYTOCHROME-P450 ENZYMES
  • SUBSTRATE REPAGLINIDE
  • SLCO1B1 POLYMORPHISM
  • 317 Pharmacy

Cite this

@article{19fba0b701c0436284f48b7e3be97397,
title = "Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications",
keywords = "DIPEPTIDYL PEPTIDASE-4 INHIBITOR, TRANSPORTING POLYPEPTIDE 1B1, CYP3A4 IN-VITRO, HEALTHY-SUBJECTS, PLASMA-CONCENTRATIONS, GENETIC POLYMORPHISMS, REPAGLINIDE PHARMACOKINETICS, CYTOCHROME-P450 ENZYMES, SUBSTRATE REPAGLINIDE, SLCO1B1 POLYMORPHISM, 317 Pharmacy",
author = "Aleksi Tornio and Mikko Niemi and Neuvonen, {Pertti J.} and Janne Backman",
year = "2012",
doi = "10.1016/j.tips.2012.03.001",
language = "English",
volume = "33",
pages = "312--322",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Ltd.",
number = "6",

}

Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. / Tornio, Aleksi; Niemi, Mikko; Neuvonen, Pertti J.; Backman, Janne.

In: Trends in Pharmacological Sciences, Vol. 33, No. 6, 2012, p. 312-322.

Research output: Contribution to journalReview ArticleScientificpeer-review

TY - JOUR

T1 - Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications

AU - Tornio, Aleksi

AU - Niemi, Mikko

AU - Neuvonen, Pertti J.

AU - Backman, Janne

PY - 2012

Y1 - 2012

KW - DIPEPTIDYL PEPTIDASE-4 INHIBITOR

KW - TRANSPORTING POLYPEPTIDE 1B1

KW - CYP3A4 IN-VITRO

KW - HEALTHY-SUBJECTS

KW - PLASMA-CONCENTRATIONS

KW - GENETIC POLYMORPHISMS

KW - REPAGLINIDE PHARMACOKINETICS

KW - CYTOCHROME-P450 ENZYMES

KW - SUBSTRATE REPAGLINIDE

KW - SLCO1B1 POLYMORPHISM

KW - 317 Pharmacy

U2 - 10.1016/j.tips.2012.03.001

DO - 10.1016/j.tips.2012.03.001

M3 - Review Article

VL - 33

SP - 312

EP - 322

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 6

ER -